Facio-Scapulo-Humeral Dystrophy clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)
Sorry, in progress, not accepting new patients
A Phase 2 Open-label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of AOC 1020 Administered Intravenously to Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)
Los Angeles, California and other locations
Last updated: